NasdaqGM - Nasdaq Real Time Price USD

Biodesix, Inc. (BDSX)

Compare
1.2700
-0.2100
(-14.19%)
At close: January 10 at 4:00:02 PM EST

Research Analysis

Earnings Per Share

Consensus EPS
 

Revenue vs. Earnings

Revenue 18.15M
Earnings -10.26M
Q4'23
Q1'24
Q2'24
Q3'24
-10M
0
10M
 

Analyst Recommendations

  • Strong Buy
  • Buy
  • Hold
  • Underperform
  • Sell
 

Analyst Price Targets

3.00
3.10 Average
1.2700 Current
3.50 High

Earnings Estimate

Currency in USD Current Qtr. (Dec 2024)Next Qtr. (Mar 2025)Current Year (2024)Next Year (2025)
No. of Analysts --------
Avg. Estimate 0000
Low Estimate 0000
High Estimate 0000
Year Ago EPS --------

Revenue Estimate

Currency in USD Current Qtr. (Dec 2024)Next Qtr. (Mar 2025)Current Year (2024)Next Year (2025)
No. of Analysts 5556
Avg. Estimate 20M20.32M70.92M93.2M
Low Estimate 19.7M19.8M70.6M89.8M
High Estimate 20.4M21.3M71.3M98.5M
Year Ago Sales 14.67M14.82M49.09M70.92M
Sales Growth (year/est) 36.35%37.13%44.48%31.42%

Earnings History

Currency in USD 12/31/2023 3/31/2024 6/30/2024 9/30/2024
EPS Est. -0.11-0.14-0.09-0.08
EPS Actual -0.1-0.14-0.08-0.07
Difference 0.0100.010.01
Surprise % 9.09%2.32%13.04%7.89%

EPS Trend

Currency in USD Current Qtr. (Dec 2024)Next Qtr. (Mar 2025)Current Year (2024)Next Year (2025)
Current Estimate 0000
7 Days Ago 0000
30 Days Ago 0000
60 Days Ago 0000
90 Days Ago 0000

EPS Revisions

Currency in USD Current Qtr. (Dec 2024)Next Qtr. (Mar 2025)Current Year (2024)Next Year (2025)
Up Last 7 Days --------
Up Last 30 Days --------
Down Last 7 Days --------
Down Last 30 Days --------

Growth Estimates

Current Qtr.Next Qtr.Current YearNext Year
BDSX --------
S&P 500 8.59%11.42%13.98%13.43%

Upgrades & Downgrades

Initiated Scotiabank: Sector Outperform 9/16/2024
Initiated Craig-Hallum: Buy 7/26/2024
Initiated TD Cowen: Buy 5/13/2024
Initiated Lake Street: Buy 5/3/2024
Reiterates Canaccord Genuity: Buy to Buy 3/4/2024
Reiterates Canaccord Genuity: Buy to Buy 12/7/2023

Related Tickers